"Welcome to SSJ Finance"

Profit & Loss Accounts

Quarterly Results

Ajanta Pharma Ltd
Industry : Pharmaceuticals - Indian - Formulations	Chairman : Mannalal B Agrawal
Home : Indian Private	Book Value: 290.1676063
BSE Code : 532331	Market Cap: 30786.01
NSE Code : AJANTPHARM	P / E : 32.9

Change Company :

Quarters:

(Rs in Cr.)

Quarterly Results

Particulars	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Type	2Qtr	1Qtr	4Qtr	3Qtr
Net Sales	1220.24	1208.56	1013.94	1101.92
Other Income	75.03	40.63	17.93	33.23
Total Income	1295.27	1249.19	1031.87	1135.15
Total Expenditure	930.65	879.16	764.29	765.59
Operating Profit	364.62	370.03	267.58	369.56
Interest	0.73	0.73	0.67	2.48
Gross Profit	363.89	369.30	266.91	367.08
Depreciation	41.92	40.31	38.76	34.93
Tax	65.97	70.73	39.10	76.38
Deferred Tax	6.47	3.29	-4.38	3.32
Reported Profit After Tax	249.53	254.97	193.43	252.45

SSJ FINANCE & SECURITIES PRIVATE LIMITED:
1st Floor, Merchant Chamber, Opp. Patkar Hall, 41, New Marine Lines, Mumbai – 400 020
SEBI Regn. Number: INZ000178436 | CDSL: IN-DP-109-2015 | ARN: 40860 | CIN: U67120MH1996PTC104822

SSJ COMMODITIES PRIVATE LIMITED:
SEBI Regn. Number: INZ000013439 | CIN: U51909MH2003PTC140481|Research Analyst SEBI Reg. No.INH000001527

Content powered by Capital Market Charts are powered by TradingView